All Stories

  1. Hepatic insulin resistance is the basis of bile acid dysmetabolism in metabolic dysfunction-associated steatotic liver disease
  2. A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease
  3. Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease
  4. Surveillance of the liver in type 2 diabetes: important but unfeasible?
  5. Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19]
  6. IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids
  7. Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis
  8. SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease
  9. The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease
  10. Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients
  11. Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis
  12. Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease
  13. The quest for the missing links in fatty liver genetics: Deep learning to the rescue!
  14. The human liver lipidome is significantly related to the lipid composition and aggregation susceptibility of low-density lipoprotein (LDL) particles
  15. Higher serum infliximab concentrations during induction predict short-term endoscopic response in patients with inflammatory bowel disease
  16. Heterogeneity of phosphatidylcholine metabolism in non-alcoholic fatty liver disease
  17. Hepatic insulin resistance is the basis of bile acid dysmetabolism in non-alcoholic fatty liver disease
  18. Marked underestimation of liver fat content as measured by magnetic resonance versus histology—a systematic review and meta-analysis
  19. Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes
  20. Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?
  21. In vitro Effects of Bacterial Exposure on Secretion of Zonulin Family Peptides and Their Detection in Human Tissue Samples
  22. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
  23. Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease
  24. Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
  25. Overfeeding Saturated Fat Increases LDL (Low-Density Lipoprotein) Aggregation Susceptibility While Overfeeding Unsaturated Fat Decreases Proteoglycan-Binding of Lipoproteins
  26. Parallel Sessions
  27. Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in Obesity
  28. The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients
  29. The PNPLA3‐I148M variant increases polyunsaturated triglycerides in human adipose tissue
  30. Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2